Interleaved and simultaneous multi‐nuclear magnetic resonance in vivo. Review of principles, applications and potential

Abstract

Magnetic resonance signals from different nuclei can be excited or received at the same time,rendering simultaneous or rapidly interleaved multi‐nuclear acquisitions feasible. The advan‐tages are a reduction of total scan time compared to sequential multi‐nuclear acquisitions or that additional information from heteronuclear data is obtained at thesame time and anatomical position. Information content can be qualitatively increased by delivering a more comprehensive MR‐based picture of a transient state (such as an exercise bout). Also, combiningnon‐proton MR acquisitions with 1Hinformation (e.g., dynamic shim updates and motion correction) can be used to improve data quality during long scans and benefits image coregistration. This work reviews the literature on interleaved and simultaneous multi‐nuclear MRI and MRS in vivo. Prominent use cases for this methodology in clinical and research applications are brain and muscle, but studies have also been carried out in other targets, including the lung, knee, breast and heart. Simultaneous multi‐nuclear measurements in the liver and kidney have also been performed, but exclusively in rodents. In this review, a consistent nomenclature is proposed, to help clarify the terminology used for this principle throughout the literature on in‐vivo MR. An overview covers the basic principles, the technical requirements on the MR scanner and the implementations realised either by MR system vendors or research groups, from the early days until today. Considerations regarding the multi‐tuned RF coils required and heteronuclear polarisation interactions are briefly discussed, and fields for future in‐vivo applications for interleaved multi‐nuclear MR pulse sequences are identified.

Potential roles of transformers in brain tumor diagnosis and treatment

“…Automated MRI with exact segmentation potential is essential for early diagnosis and treatment progress monitoring. [43] Tumor detection is the first step in BT diagnosis, based on MRI segmentation and often carried out manually, making it a labor-and timeintensive task; since tumors exist in various forms and dimensions, this task requires expertise. The length of this assessment process can be reduced by automating BT segmentation.…”

Parallel detection of multi-contrast MRI and Deuterium Metabolic Imaging (DMI) for time-efficient characterization of neurological diseases

“…As a result, 18 FDG-PET is successfully used to characterize various cancers outside of the brain. Nevertheless, in patients with brain tumors, the high baseline glucose uptake in healthy brain can lead to low tumor-to-brain image contrast, often resulting in inconclusive 18 FDG-PET scans 4,12,13 . In addition, the exposure to ionizing radiation during 18 FDG-PET complicates repeated scanning as well as the use in pediatric patients.…”

“…Positron emission tomography (PET) of the glucose analog deoxyglucose (DG) labeled with the radiotracer 18 F is the most prominent metabolic imaging approach in the clinic, particularly in the setting of cancer. An elevated 18 FDG uptake indicates an increasing demand of glucose, which is often correlated with a specific type of glucose metabolism observed in aggressive tumors (the Warburg effect). As a result, 18 FDG-PET is successfully used to characterize various cancers outside of the brain.…”

Sodium and quantitative hydrogen parameter changes in muscle tissue after eccentric exercise and in delayed‐onset muscle soreness assessed with magnetic resonance imaging

“…Thus, the results at t1 must be interpreted with caution given the long acquisition times and highly dynamic postexercise state. In future studies, the time gap between the acquisition of 23 Na and 1 H MRI data might be reduced by applying techniques that enable interleaved 58 or simultaneous 59,60 acquisition of 23 Na and 1 H MRI data.…”